Potential of nanobiotechnology in the management of glioblastoma multiforme

Glioblastoma: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies

Volumn , Issue , 2010, Pages 399-419

  Jain, Kewal K ^a  

^a NONE   (Switzerland)

Author keywords

Blood brain barrier; Brain cancer; Brain tumors; Cancer chemotherapy; Gene therapy; Glioblastoma multiforme; Nanobiotechnology; Nanooncology; Nanoparticles; Neurooncology

Indexed keywords

EID: 79955638157     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-0410-2_19     Document Type: Chapter

References (50)

1. Abraham SA, Waterhouse DN, Mayer LD et al (2005) The liposomal formulation of doxorubicin. Methods Enzymol 391:71-97
2. Ambruosi A, Gelperina S, Khalansky A et al (2006) Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly (butyl cyanoacrylate) nanoparticles in a rat glioma model. J Microencapsul 23:582-592
3. Anderson EA, Isaacman S, Peabody DS et al (2006) Viral nanoparticles donning a paramagnetic coat: conjugation of MRI contrast agents to the MS2 capsid. Nano Lett 6:1160-1164
4. Anderson SA, Glod J, Arbab AS et al (2005) Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 105:420-425
5. Béduneau A, Saulnier P, Benoit JP (2007) Active targeting of brain tumors using nanocarriers. Biomaterials. 28:4947-4967
6. Bernardi RJ, Lowery AR, Thompson PA et al (2008) Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines. J Neurooncol 86:165-172
7. Cai W, Chen K, Li ZB et al (2007) Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature. J Nucl Med 48:1862-1870
8. Jain KK (2005) The role of nanobiotechnology in drug discovery. Drug Discov Today 10:1435-1442
9. Jain KK (2006) Future prospects for the cure of brain cancer. Technol Cancer Res Treat 5:183-184
10. Jain KK (2007a) Role of nanobiotechnology in drug discovery. In: Guzman CA, Feuerstein G (eds) Pharmaceutical biotechnology. Landes Press, Austin, TX. http://eurekah.com/chapter/3570
11. Jain KK (2007b) Use of nanoparticles for drug delivery in glioblastoma multiforme. Expert Rev Neurother 7:363-372
12. Jain KK (2008a) Recent advances in nanooncology. Technol Cancer Res Treat 7:1-14
13. Jain KK (2008b) A handbook of nanomedicine. Humana/Springer, Totowa, NJ
14. Jain KK (2009) Nanobiotechnology: applications, markets and companies. Jain PharmaBiotech Publications, Basel, Switzerland
15. Jeong YI, Kim SH, Jung TY et al (2006) Polyion complex micelles composed of all-trans retinoic acid and poly (ethylene glycol)-grafted-chitosan. J Pharm Sci 95:2348-2360
16. Jeuken JWM, Van Der Maazen RWM, Wesseling P (2006) Molecular diagnostics as a tool to personalize treatment in adult glioma patients. Technol Cancer Res Treat 5:215-229
17. Jordan A, Scholz R, Maier-Hauff K et al (2006) The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J Neurooncol 78:7-14
18. Kircher MF, Mahmood U, King RS et al (2003) A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res 63:8122-8125
19. Kopelman R, Philbert M, Koo YEL et al (2005) Multifunctional nanoparticle platforms for in vivo MRI enhancement and photodynamic therapy of a rat brain cancer. J Magn Magn Mater 293:404-410
20. Krauze MT, Forsayeth J, Park JW, Bankiewicz KS (2006) Real-time imaging and quantification of brain delivery of liposomes. Pharm Res 23:2493-2504
21. Lopez KA, Waziri AE, Canoll PD, Bruce JN (2006) Convection-enhanced delivery in the treatment of malignant glioma. Neurol Res 28:542-548
22. Lu W, Sun Q, Wan J, She Z, Jiang XG (2006) Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration. Cancer Res 66:11878-11887
23. Madhankumar AB, Slagle-Webb B, Mintz A et al (2006) Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme. Mol Cancer Ther 5:3162-3169
24. Mamot C, Drummond DC, Noble CO et al (2005) Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo. Cancer Res 65:11631-11638
25. Maier-Hauff K, Rothe R, Scholz R et al (2007) Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J Neurooncol 81:53-60
26. Morgan MT, Nakanishi Y, Kroll DJ, Griset AP et al (2006) Dendrimer-encapsulated camptothecins: increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro. Cancer Res 66:11913-11921
27. Muldoon LL, Sandor M, Pinkston KE, Neuwelt EA (2005) Imaging, distribution, and toxicity of superparamagnetic iron oxide magnetic resonance nanoparticles in the rat brain and intracerebral tumor. Neurosurgery 57:785-796
28. Na HB, Lee JH, An K et al (2007) Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew Chem Int Ed Engl 46:5397-5401
29. Neuwelt EA, Varallyay P, Bago AG et al (2004) Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours. Neuropathol Appl Neurobiol 30:456-471
30. Nikanjam M, Gibbs AR, Hunt CA et al (2007) Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme. J Control Release 124:163-171
31. Noble CO, Krauze MT, Drummond DC et al (2006) Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors: pharmacology and efficacy. Cancer Res 66:2801-2806
32. Peters A, Veronesi B, Calderon-Garciduenas L et al (2006) Translocation and potential neurological effects of fine and ultrafine particles: a critical update. Part Fibre Toxicol 3:13
33. Petri B, Bootz A, Khalansky A et al (2007) Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly (butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants. J Control Release 117:51-58
34. Plotkin M, Gneveckow U, Meier-Hauff K et al (2006) 18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma. Int J Hyperthermia 22:319-325
35. Reddy GR, Bhojani MS, McConville P et al (2006) Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin Cancer Res 12:6677-6686
36. Reszka RC, Jacobs A, Voges J (2005) Liposome-mediated suicide gene therapy in humans. Methods Enzymol 391:200-208
37. Saito R, Bringas JR, McKnight TR et al (2004) Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging. Cancer Res 64:2572-2579
38. Sakamoto J, Annapragada A, Decuzzi P, Ferrari M (2007) Antibiological barrier nanovector technology for cancer applications. Expert Opin Drug Deliv 4:359-369
39. Schneider T, Becker A, Ringe K et al (2008) Brain tumor therapy by combined vaccination and antisense oligonucleotide delivery with nanoparticles. J Neuroimmunol 195:21-27
40. Serpe L, Guido M, Canaparo R et al (2006) Intracellular accumulation and cytotoxicity of doxorubicin with different pharmaceutical formulations in human cancer cell lines. J Nanosci Nanotechnol 6:3062-3069
41. Simberg D, Duza T, Park JH et al (2007) Biomimetic amplification of nanoparticle homing to tumors. Proc Natl Acad Sci U S A 104:932-936
42. Steiniger SC, Kreuter J, Khalansky AS et al (2004) Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles. Int J Cancer 109:759-767
43. Trehin R, Figueiredo JL, Pittet MJ et al (2006) Fluorescent nanoparticle uptake for brain tumor visualization. Neoplasia 8:302-311
44. Tsutsui Y, Tomizawa K, Nagita M et al (2007) Development of bionanocapsules targeting brain tumors. J Control Release 122:159-164
45. Wang J, Yong WH, Sun Y et al (2007) Receptor-targeted quantum dots: fluorescent probes for brain tumor diagnosis. J Biomed Opt 12:044021
46. Wu G, Barth RF, Yang W et al (2004) Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy. Bioconjug Chem 15:185-194
47. Xie J, Wang CH (2006) Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro. Pharm Res 23:1817-1826
48. Yang W, Barth RF, Wu G et al (2006) Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4. Clin Cancer Res 12:3792-3802
49. Yu W, Pirollo KF, Rait A et al (2004) A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene. Gene Ther 11:1434-1440
50. Zhang Y, Sun C, Kohler N et al (2004) Self-assembled coatings on individual monodisperse magnetite nanoparticles for efficient intracellular uptake. Biomed Microdevices 6:33-40